These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
905 related articles for article (PubMed ID: 16737933)
21. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation. Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321 [TBL] [Abstract][Full Text] [Related]
22. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278 [TBL] [Abstract][Full Text] [Related]
23. Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Fruehauf S; Klaus J; Huesing J; Veldwijk MR; Buss EC; Topaly J; Seeger T; Zeller LW; Moehler T; Ho AD; Goldschmidt H Bone Marrow Transplant; 2007 Jun; 39(12):743-50. PubMed ID: 17450182 [TBL] [Abstract][Full Text] [Related]
24. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF]. Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058 [TBL] [Abstract][Full Text] [Related]
25. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)]. Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179 [TBL] [Abstract][Full Text] [Related]
26. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Arbona C; Prosper F; Benet I; Mena F; Solano C; Garcia-Conde J Bone Marrow Transplant; 1998 Jul; 22(1):39-45. PubMed ID: 9678794 [TBL] [Abstract][Full Text] [Related]
27. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
28. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor. Gyger M; Stuart RK; Perreault C Bone Marrow Transplant; 2000 Jul; 26(1):1-16. PubMed ID: 10918400 [TBL] [Abstract][Full Text] [Related]
29. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors. Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468 [TBL] [Abstract][Full Text] [Related]
30. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Steidl U; Fenk R; Bruns I; Neumann F; Kondakci M; Hoyer B; Gräf T; Rohr UP; Bork S; Kronenwett R; Haas R; Kobbe G Bone Marrow Transplant; 2005 Jan; 35(1):33-6. PubMed ID: 15531906 [TBL] [Abstract][Full Text] [Related]
31. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408 [TBL] [Abstract][Full Text] [Related]
32. Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation. Siegert W; Beyer J; Kingreen D; Blasczyk R; Baurmann H; Schwella N; Schleicher J; Kirsch A; Huhn D Bone Marrow Transplant; 1998 Sep; 22(6):579-83. PubMed ID: 9758347 [TBL] [Abstract][Full Text] [Related]
33. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284 [TBL] [Abstract][Full Text] [Related]
34. Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primates. Larsen SR; Chng K; Battah F; Martiniello-Wilks R; Rasko JE Stem Cells; 2008 Nov; 26(11):2974-80. PubMed ID: 18719223 [TBL] [Abstract][Full Text] [Related]
35. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Magro E; Regidor C; Cabrera R; Sanjuán I; Forès R; Garcia-Marco JA; Ruiz E; Gil S; Bautista G; Millán I; Madrigal A; Fernandez MN Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070 [TBL] [Abstract][Full Text] [Related]
36. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study. Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366 [TBL] [Abstract][Full Text] [Related]
37. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective. Bargetzi MJ; Passweg J; Baertschi E; Schoenenberger A; Gwerder C; Tichelli A; Burger J; Mingrone W; Herrmann R; Gratwohl A; Wernli M Bone Marrow Transplant; 2003 Jan; 31(2):99-103. PubMed ID: 12621490 [TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation. Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR; Mayani H Ann Hematol; 2006 Feb; 85(2):113-20. PubMed ID: 16311734 [TBL] [Abstract][Full Text] [Related]
39. Mobilization and collection of allogeneic peripheral blood progenitor cells for transplantation. Wiesneth M; Schreiner T; Friedrich W; Bunjes D; Duncker C; Krug E; Maccari B; Müller S; Nowak S; Kubanek B Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S21-4. PubMed ID: 9712487 [TBL] [Abstract][Full Text] [Related]
40. Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors. Zhao XY; Chang YJ; Xu LP; Liu DH; Liu KY; Huang XJ Bone Marrow Transplant; 2009 Dec; 44(11):721-8. PubMed ID: 19377516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]